silver has been researched along with trichostatin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boros, IM; Igaz, N; Kiricsi, M; Kónya, Z; Kovács, D; Rázga, Z | 1 |
| Bai, DP; Gurunathan, S; Huang, FH; Huang, YF; Massimo, DF; Zhang, GL; Zhang, XF | 1 |
2 other study(ies) available for silver and trichostatin a
| Article | Year |
|---|---|
Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles.
Topics: Antineoplastic Agents; Chromatin; DNA Damage; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Metal Nanoparticles; Silver | 2016 |
Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3).
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carotenoids; Cell Death; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Female; Graphite; Humans; Hydroxamic Acids; Lycopene; Metal Nanoparticles; Ovarian Neoplasms; Reactive Oxygen Species; Silver | 2017 |